CTOR

Citius Oncology, Inc.

Contracts

Total Value

Stock Metrics

2.7%

Short % Float

6.2d to cover · Moderate squeeze

15.2%

Inst % Float

10 holders · 2026-06-30

Armistice Capital,

Top Holder

9.4% of float

14.9M sh

Public Float

84/100

Dilution Score

Critical

6 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

84/100

CRITICAL

Inst: 15.21% · Top: Armistice Capital, LLC

Biotech Analytics

Oncology

14.5

Dilution Risk: CRITICALSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications90

Dilution Risk84

Clinical Trials0

Short Interest10